NCT07505056 is a Phase 3 clinical trial of Jianpi Lishi Jiedu Granules in Colorectal Adenoma, sponsored by Nanjing First Hospital, Nanjing Medical University.

Who is sponsoring NCT07505056?

NCT07505056 is sponsored by Nanjing First Hospital, Nanjing Medical University.

What drugs are being tested in NCT07505056?

Interventions in NCT07505056: Jianpi Lishi Jiedu Granules, Placebo granules.

What condition does NCT07505056 study?

NCT07505056 studies Colorectal Adenoma.

Is NCT07505056 still recruiting?

NCT07505056 is currently not yet recruiting. Last updated 1 April 2026.

Last reviewed 2026-04-01 · How we verify

NCT07505056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas

Not yet recruiting Phase 3 Last updated 1 April 2026

What this trial tests

Phase 3 trial testing Jianpi Lishi Jiedu Granules in Colorectal Adenoma in 376 participants. Not yet recruiting.

Timeline

1 May 2026

Primary endpoint
31 December 2026

29 February 2028

Quick facts

Lead sponsor	Nanjing First Hospital, Nanjing Medical University
Phase	Phase 3
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	376
Start date	1 May 2026
Primary completion	31 December 2026
Estimated completion	29 February 2028

Drugs / interventions tested

Jianpi Lishi Jiedu Granules
Placebo granules

Conditions studied

Colorectal Adenoma — all drugs for Colorectal Adenoma →

Sponsor

Nanjing First Hospital, Nanjing Medical University

Who can join

Adults 18 to 80, any sex, with Colorectal Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This multicenter, randomized, double-blind, placebo-controlled trial aims to evaluate the efficacy and safety of Jianpi Lishi Jiedu Granules in preventing postoperative recurrence of colorectal advanced adenoma. A total of 376 patients aged 18-80 years with endoscopically resected advanced adenoma and diagnosed with Spleen Deficiency and Dampness Toxin syndrome will be enrolled and randomly assigned to receive either Jianpi Lishi Jiedu Granules or placebo for 3 months. The primary endpoint is the adenoma recurrence rate at 1 year post-treatment, assessed by colonoscopy and pathological examination. Secondary endpoints include malignant transformation rate, TCM syndrome improvement, quality of life, gastrointestinal symptoms, and exploratory analyses of gut microbiota and inflammatory cytokines.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Colorectal Adenoma

Currently open trials in the same condition.

NCT07095517 — Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors · Phase 1 · recruiting
NCT06979232 — Enhanced White Light Endoscopy Versus Conventional White Light Endoscopy for Colorectal Adenoma Detection: A Randomized · NA · recruiting
NCT07035691 — New bioMarkers tO straTIfy cOlorectal caNcer Referrals · recruiting
NCT06715384 — Evaluation of a CAM System for Colorectal Polyp Size Measurement · NA · recruiting
NCT06612281 — Evaluation of Gixam's Performance in a FIT Negative Population · Phase 2 · recruiting

Other Nanjing First Hospital, Nanjing Medical University trials

Trials by the same sponsor.

NCT07349979 — PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy · NA · not yet recruiting
NCT07397234 — Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation · NA · not yet recruiting
NCT07455448 — Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study · completed
NCT07385885 — Ultrasound-guided Non-invasive Simulation in Anesthesia Residency Training · NA · not yet recruiting
NCT07374458 — Effects of Esketamine and Bilateral Lower Limb Elevation on Hemodynamic Stability During Induction of General Anesthesia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07505056 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanjing First Hospital, Nanjing Medical University
Last refreshed: 1 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07505056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing